Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Investors
Resources
Sample Case Studies
Clinical Research Repository
Customer Support
Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Careers
Investors
Resources
Case Studies
Clinical Research Repository
Customer Support
Legal
Privacy Policy
Disclaimer
Acceptable Use Policy
Contact Us
✕
No results
See all results
PDF
June 5, 2019
June 5, 2019
Underwritten rights issue prospectus lodged with ASIC
June 5, 2019
June 5, 2019
Over subscribed capital raising to fast track strategy
June 5, 2019
June 5, 2019
Trading halt
June 5, 2019
June 5, 2019
Final directors interest notice – D Brookes
June 5, 2019
June 5, 2019
Change to board of directors
June 5, 2019
June 5, 2019
AtCor Medical announces first step in major strategic repositioning
June 5, 2019
June 5, 2019
Resignation of CFO and company secretary
June 5, 2019
June 5, 2019
Half yearly report and accounts
June 5, 2019
June 5, 2019
AtCor Medicals’ XCEL device clinically validated in third party study
Load more
Contact Us
No results
See all results
This website uses cookies to improve your experience. By using this website you agree to our
Data Protection Policy
.
Read more
Accept all
